Skip to main content

Corporate insider profile

Raymond Anderson Insider Trades

Raymond Anderson has reported no open-market purchases on SEC Form 4 and is a net seller of $565,936 across 1 company. The most recent open-market transaction was reported on Nov 2, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of Monopar Therapeutics (MNPR).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$565,935.78
Latest transaction
Nov 2, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 2, 2026Monopar Therapeutics (MNPR)Corporate insiderSale3,142$68.35$214,747
Aug 25, 2026Monopar Therapeutics (MNPR)Corporate insiderSale3,142$111.77$351,189

Common questions

Raymond Anderson insider trading FAQ

Is Raymond Anderson buying or selling stock?
Across all SEC Form 4 open-market filings on record, Raymond Anderson is a net seller of $565,936, with no open-market purchases reported. The latest transaction was reported on Nov 2, 2026.
Which companies does Raymond Anderson report insider trades for?
Raymond Anderson has reported open-market trades in Monopar Therapeutics (MNPR). The latest SEC-reported relationship is Corporate insider of Monopar Therapeutics (MNPR).
Where does Raymond Anderson's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1362489, and refreshes this page daily.